2,469
Views
21
CrossRef citations to date
0
Altmetric
Food & Nutrition Science

Development of hypoallergenic galacto-oligosaccharides on the basis of allergen analysis

, , , , &
Pages 100-108 | Received 23 Jul 2013, Accepted 14 Oct 2013, Published online: 30 Apr 2014
 

Abstract

Galacto-oligosaccharides (GOSs) are recognized as prebiotics beneficial to human health through their abilities to modulate gut microbiota. On the other hand, it has been reported that immediate allergic reactions are caused by a GOS product (Bc-GOS) produced by treating lactose with β-galactosidase derived from Bacillus circulans. The objective of this study was to create a safer GOS product that is less likely to cause GOS-induced allergy (GOS-AL). First, we identified two derivatives of tetrasaccharide sugar chains in Bc-GOS as the factors responsible for GOS-AL by histamine release test (HRT) using blood samples obtained from two GOS-AL patients. Through our search for non-allergic GOS, we developed a new GOS product, SK-GOS, which was produced by catalyzing lactose with β-galactosidase derived from Sporobolomyces singularis and Kluyveromyces lactis. We regard it as a hypoallergic and safe GOS product that does not cause GOS-AL.

Graphical Abstract

Galβ1-4(Galβ1-4Galβ1-6)Glc (4P-X) in GOS was an allergen. 4P-X exhibited strong histamine release activity. GOS having little 4P-X level was hypoallergenic.

Acknowledgments

This study was conducted in the cooperation with Dr. Takashi Katutani (Katsutani Clinic, Hiroshima) and Dr. Eisaku Sakihara (Okinawa Prefectural Chubu Hospital). We would like to express our deepest gratitude to all of them. We also wish to thank Dr. Shuichi Kaminogawa (Professor Emeritus, University of Tokyo) for valuable suggestions. Here was no conflict of interest with any third party as to the contents of this study.

Notes

Abbreviations: GOS, galacto-oligosaccharide; GOS-AL, GOS-allergy; HRT, histamine release test; PA, pyridylamination; Gal, galactose; Glc, glucose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.